Teksin Zeynep S, Hom Kelli, Balakrishnan Anand, Polli James E
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
J Control Release. 2006 Nov;116(1):50-7. doi: 10.1016/j.jconrel.2006.08.020. Epub 2006 Sep 6.
Parallel Artificial Membrane Permeability Assay (PAMPA) is a method to screen drug candidates for membrane permeability. The objective was to characterize the transport of a model weak base, metoprolol, across a three lipid-component PAMPA system (denoted A-PAMPA, for anionic-PAMPA) and challenge ion pairing as a mechanism for metoprolol transport. A-PAMPA was designed to mimic the lipid composition of the enterocyte's plasma membrane and included 1,2-dioleoyl-sn-glycero-3-[phospho-l-serine] (PS18:1) as an anionic lipid-component. Metoprolol flux was measured across A-PAMPA, as well as across three other PAMPA systems. Permeability studies were conducted under various conditions, with varying pH, ionic strength, and presence/absence of competing cations. Permeabilities of mannitol and benzoic acid, as model neutral and anionic solutes, were also measured. PAMPA membrane fluidity was inferred from anisotropy measurements in liposomes. Ion pairing between metoprolol and PS18:1 was assessed via NMR. Metoprolol transport across A-PAMPA was dominated by an ion pair-mediated mechanism (i.e. metoprolol-PS18:1 complex), rather than a membrane fluidity-mediated mechanism. Compared to other PAMPA systems, metoprolol permeability across A-PAMPA and PS18:1 was high. Permeability and anisotropy values suggested PS18:1 selectively facilitated metoprolol transport, while neutral lipid did not. Additional studies supporting ion pairing of metoprolol across A-PAMPA showed that a) metoprolol transport was self-inhibited across A-PAMPA but not across neutral lipid PAMPA; b) competing cations reduced metoprolol permeability across A-PAMPA but not across neutral lipid PAMPA; and c) NMR spectrum of a mixture of metoprolol and PS18:1 showed a broadening of some metoprolol peaks, presumably due to metoprolol interaction with anionic lipid. Metoprolol transport across a three lipid-component PAMPA system that contained anionic lipid was facilitated by apparent ion pairing.
平行人工膜通透性测定法(PAMPA)是一种筛选具有膜通透性的候选药物的方法。目的是表征模型弱碱美托洛尔在三脂质成分PAMPA系统(称为A-PAMPA,即阴离子型PAMPA)中的转运情况,并验证离子对形成作为美托洛尔转运机制的可能性。A-PAMPA旨在模拟肠上皮细胞质膜的脂质组成,包含1,2-二油酰基-sn-甘油-3-[磷酸-L-丝氨酸](PS18:1)作为阴离子脂质成分。测定了美托洛尔在A-PAMPA以及其他三种PAMPA系统中的通量。在不同条件下进行通透性研究,包括不同的pH值、离子强度以及竞争性阳离子的存在与否。还测定了作为模型中性和阴离子溶质的甘露醇和苯甲酸的通透性。通过脂质体中的各向异性测量推断PAMPA膜的流动性。通过核磁共振评估美托洛尔与PS18:1之间的离子对形成。美托洛尔在A-PAMPA中的转运主要由离子对介导机制(即美托洛尔-PS18:1复合物)主导,而非膜流动性介导机制。与其他PAMPA系统相比,美托洛尔在A-PAMPA和PS18:1中的通透性较高。通透性和各向异性值表明PS18:1选择性地促进了美托洛尔的转运,而中性脂质则不然。支持美托洛尔在A-PAMPA上形成离子对的其他研究表明:a)美托洛尔在A-PAMPA上的转运存在自抑制现象,而在中性脂质PAMPA上则不存在;b)竞争性阳离子降低了美托洛尔在A-PAMPA上的通透性,但在中性脂质PAMPA上则没有;c)美托洛尔与PS18:1混合物的核磁共振谱显示一些美托洛尔峰变宽,可能是由于美托洛尔与阴离子脂质相互作用所致。美托洛尔在含有阴离子脂质的三脂质成分PAMPA系统中的转运通过明显的离子对形成得到促进。